Exchange Traded Concepts’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
DTC
APM
WP
PAMS
Exchange Traded Concepts's EDIT Position: Q2 2023 in Review
Exchange Traded Concepts sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 96,261 shares — an estimated $698K sold.
Exchange Traded Concepts first reported a position in EDIT in Q4 2019 and held it in 13 quarters. The position peaked at $5.43M in Q2 2021. 237 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.
- Exchange Traded Concepts reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
- Exchange Traded Concepts sold 96,261 Editas Medicine shares in Q2 2023, an estimated $698K.
- Exchange Traded Concepts first reported a position in Editas Medicine in Q4 2019 and held it in 13 quarters.
- Exchange Traded Concepts's Editas Medicine position peaked at $5.43M in Q2 2021.
- 237 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.
Based on Exchange Traded Concepts's 13F filing for Q2 2023, filed 20 Jul 2023.